No Detail Found!

Dexketoprofen vs. Tamsulosin vs. Silodosin vs. Tadala l as medical expulsive therapy for distal ureteral stones in men

Author(s)
Metin Gur Department of Urology, Gazi Hospital,Samsun,Turkey
Muhammet Bahaettin Ulu Department of Urology, Gazi Hospital,Samsun,Turkey
Suleyman Tumer Caliskan Department of Urology, Gazi Hospital,Samsun,Turkey
Kemal Ozturk Department of Urology, Gazi Hospital,Samsun,Turkey
Ekrem Akdeniz Department of Urology, Health Practice and Research Center, University of Health Sciences,Samsun,Turkey
Abstract
Objective: To assess the e ectiveness of the use of dexketoprofen, tamsulosin, silodosin, and tadala l in medical expulsive therapy for distal ureteral stones in male patients. Study Design: Cohort study. Place and Duration of Study: Department of Urology, Gazi Hospital, Samsun, Turkey, from March 2020 to March 2021. Methodology: Adult males satisfying the inclusion criteria were randomly assigned into dexketoprofen (Group 1), tamsulosin (Group 2), silodosin (Group 3), or tadala l (Group 4) treatment arms. The primary endpoint consisted of the stone expulsion rate at the end of four weeks, while the secondary endpoints were the expulsion rate after two weeks and the occurrence of adverse events. Clinical ndings were then compared among the study groups. Results: Altogether 193 patients, 50 (25.9%) in group 1, 48 (24.9%) in group 2, 49 (25.4%) in group 3, and 46 (23.8%) in group 4, were enrolled in the study. No signi cant di erence was determined in terms of age, body mass index, stone characteristics, expulsion time, pain episodes, or total analgesic consumption among the four groups. Expulsion rates in the fourth week were 48%, 79.2%, 81.6%, and 78.3% in groups 1, 2, 3, and 4, respectively. Stone expulsion rates were signi cantly greater in groups 2, 3, and 4 compared to group 1 (p <0.001), but no signi cant di erences were determined between groups 2, 3, and 4. No severe adverse e ects occurred throughout the study period. Conclusion: Tamsulosin, silodosin and tadala l exhibited higher expulsion rates for distal ureteral stones in male patients, although none was signi cantly superior to the others. All three are safe, e cacious, and well-tolerated, with only very minor side-e ects.
Publication Details
Page(s) 947-952
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 31, Issue: 8, Year: 2021

Request the full text from PASTIC

Keywords
Tamsulosin, Dexketoprofen, Medical Expulsive Therapy, Distal Ureteral Stones, Silodosin, Tadala l
0

Citations

0

Downloads

86

Views